1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5 PMid:31986264

2. Ashour HM, Elkhatib WF, Rahman M, Elshabrawy HA. Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks. Pathogens. 2020; 9(3):186-99. doi:10.3390/pathogens9030186 PMid:32143502 PMCid:PMC7157630

3. Taj A, Arabasadi R, Ayatnia M. Effective and comprehensive management process against COVID-19: the golden key to increasing safety in the hospital environment. Novel Clin Med. 2024; 3(1): 58-59. doi: 10.22034/ncm.2023.381578.1068

4. Zorriehzahra MJ, Dadar M, Ziarati M, Seidgar M, Hassantabar F, Ghasemi M, et al. A Perspective on the Origin of COVID-19 and Its Epidemic Situation in Iran and the World. J Mari Med. 2020; 2(1):41-52.

5. Chu DK, Pan Y, Cheng SM, Hui KP, Krishnan P, Liu Y, et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem. 2020; 66(4):549-55. doi:10.1093/clinchem/hvaa029 PMid:32031583 PMCid:PMC7108203

6. Selvaraj V, Dapaah-Afriyie K, Finn A, Flanigan TP. Short-term dexamethasone in Sars-CoV-2 patients. RI Med J. 2020; 103(6):39-43.

7. Ung COL. Community pharmacist in public health emergencies: quick to action against the coronavirus 2019-nCoV outbreak. Res Social Adm Pharm. 2020; 2(1):22-9. doi:10.1016/j.sapharm.2020.02.003 PMid:32081569 PMCid:PMC7129623

8. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395 (10223):507-13. doi:10.1016/S0140-6736(20)30211-7 PMid:32007143

9. Taheri S. A Review on Coronavirus Disease (COVID-19) and what is Known about it. Depiction Health. 2020; 11(1):87-93. doi:10.34172/doh.2020.09

10. Ganji A, Mosayebi G, Khaki M, Ghazavi A. A review of the 2019 novel Coronavirus (Covid-19): Immunopathogenesis, molecular biology and clinical aspects. J Arak Univ Med Sci. 2020;23(1):8-21. doi:10.32598/JAMS.23.1.51.5

11. Koksoy Vayisoglu S, Aydin Besen M, Oncu E. Perspectives of midwifery and nursing students on recommending the COVID-19 vaccine to women of reproductive age and factors influencing counseling competency: a cross-sectional study. Novel Clin Med. 2024; 3(1): 1-11. doi: 10.22034/ncm.2023.418212.1133

12. Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiol. 2020;2(3):200490. doi:10.1148/radiol.2020200490 PMid:32083985 PMCid:PMC7233368

13. Baranovskii DS, Klabukov ID, Krasilnikova OA, Nikogosov DA, Polekhina NV, Baranovskaia DR, et al. Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumonia. Curr Med Res Opin. 2021; 37(1):21-5. doi:10.1080/03007995.2020.1853510 PMid:33210948 PMCid:PMC7738209

14. Lagadinou M, Salomou E, Zareifopoulos N, Marangos M, Gogos C, Velissaris D. Prognosis of COVID-19: changes in laboratory parameters. Age 2020; 62(13.4):47-16.42.

15. Theoharides T, Conti P. Dexamethasone for COVID-19? Not so fast. J Biol Regul Homeost Agents. 2020; 34(3):10.23812.

16. Liang T. Handbook of COVID-19 prevention and treatment. Zhejiang Zhejiang University School of Medicine; 2020.

17. Samadizadeh S, Masoudi M, Rastegar M, Salimi V, Shahbaz MB, Tahamtan A. COVID-19: Why does disease severity vary among individuals? Respirator Med. 2021; 180(3):1063-56. doi:10.1016/j.rmed.2021.106356 PMid:33713961 PMCid:PMC7934673

18. Cheng Y, Cheng G, Chui C, Lau F, Chan PK, Ng MH, et al. ABO blood group and susceptibility to severe acute respiratory syndrome. Jama. 2005; 293(12):1447-51 doi:10.1001/jama.293.12.1450-c PMid:15784866

19. Zhang Y, Garner R, Salehi S, La Rocca M, Duncan D. Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies. Ann Hematol. 2021; 100(5):1123-32. doi:10.1007/s00277-021-04489-w PMid:33686492 PMCid:PMC7939543

20. Ayatollahi AA, Aghcheli B, Amini A, Nikbakht H, Ghassemzadehpirsala P, Behboudi E, et al. Association between blood groups and COVID-19 outcome in Iranian patients. Future Virol. 2021; 16(10):657-65. doi:10.2217/fvl-2021-0090 PMid:34589135 PMCid:PMC8462120

21. Kabrah SM, Kabrah AM, Flemban AF, Abuzerr S. Systematic review and meta-analysis of the susceptibility of ABO blood group to COVID-19 infection. Transfusion Apheresis Sci. 2021; 60(4): 103169. doi:10.1016/j.transci.2021.103169 PMid:34045120 PMCid:PMC8139534

22. Liu N, Zhang T, Ma L, Zhang H, Wang H, Wei W, et al. The impact of ABO blood group on COVID-19 infection risk and mortality: A systematic review and meta-analysis. Blood Rev. 2021; 48(3):1007-85. doi:10.1016/j.blre.2020.100785 PMid:33309392 PMCid:PMC7834371

23. Garg I, Srivastava S, Dogra V, Bargotya M, Bhattar S, Gupta U, et al. Potential association of COVID-19 and ABO blood group: An Indian study. Microb Pathog. 2021; 158: 105008. doi:10.1016/j.micpath.2021.105008 PMid:34087389 PMCid:PMC8168328

24. Kim Y, Latz CA, DeCarlo CS, Lee S, Png CM, Kibrik P, et al. Relationship between blood type and outcomes following COVID-19 infection. Vascular Surg. 2021;34(3):125-31. doi:10.1053/j.semvascsurg.2021.05.005 PMid:34642032 PMCid:PMC8286549

25. Boudin L, Janvier F, Bylicki O, Dutasta F. ABO blood groups are not associated with the risk of acquiring SARS-CoV-2 infection in young adults. Haematologica. 2020; 105(12):2841. doi:10.3324/haematol.2020.265066 PMid:33256383 PMCid:PMC7716357

26. Hoiland RL, Fergusson NA, Mitra AR, Griesdale DE, Devine DV, Stukas S, et al. The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19. Blood Adv. 2020; 4(20):4981-9. doi:10.1182/bloodadvances.2020002623 PMid:33057633 PMCid:PMC7594392

27. Zietz M, Zucker J, Tatonetti N. Testing the association between blood type and COVID-19 infection, intubation, and death. medRxiv Prepr. Serv Health Sci. 2020; 1(2):44-57 doi:10.1038/s41467-020-19623-x PMid:33188185 PMCid:PMC7666188

28. Wu Y, Feng Z, Li P, Yu Q. Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19. Clin Chim Acta. 2020; 509(5):220-3. doi:10.1016/j.cca.2020.06.026 PMid:32562665 PMCid:PMC7832938

29. Ray JG, Schull MJ, Vermeulen MJ, Park AL. Association between ABO and Rh blood groups and SARS-CoV-2 infection or severe COVID-19 illness: a population-based cohort study. Ann Internal Med. 2021; 174(3):308-15 doi:10.7326/M20-4511 PMid:33226859 PMCid:PMC7711653

30. Latz CA, DeCarlo C, Boitano L, Png C, Patell R, Conrad MF, et al. Blood type and outcomes in patients with COVID-19. Ann Hematol. 2020; 99(9): 2113-8 doi:10.1007/s00277-020-04169-1 PMid:32656591 PMCid:PMC7354354

31. Padhi S, Suvankar S, Dash D, Panda VK, Pati A, Panigrahi J, et al. ABO blood group system is associated with COVID-19 mortality: An epidemiological investigation in the Indian population. Transf Clin Et Biol. 2020; 27(4):253-8. doi:10.1016/j.tracli.2020.08.009 PMid:32987167 PMCid:PMC7518849

32. National Health Commission of China. The guidelines for diagnosis and treatment of novel coronavirus (2019‐nCoV) infected pneumonia (the sixth edition draft) issued by the National Health Commission of China.

33. Https://www.uptodate.com/contents/table-of-contents/calculators/rheumatology-calculators

34. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-9. doi:10.1001/jama.2020.1585 PMid:32031570 PMCid:PMC7042881

35. Https://www.ibto.ir

36. Ishaq U, Malik A, Malik J, Mehmood A, Qureshi A, Laique T, et al. Association of ABO blood group with COVID-19 severity, acute phase reactants and mortality. Plos One. 2021; 16(12):261-432. doi:10.1371/journal.pone.0261432 PMid:34905588 PMCid:PMC8670663

37. Barnkob MB, Pottegård A, Støvring H, Haunstrup TM, Homburg K, Larsen R, et al. Reduced prevalence of SARS-CoV-2 infection in ABO blood group O. Blood Adv 2020; 4(20): 4990-3. doi:10.1182/bloodadvances.2020002657 PMid:33057631 PMCid:PMC7594382

38. Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, et al. Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility. Clin Infect Dis. 2021; 73(2):328-31. doi:10.1093/cid/ciaa1150 PMid:32750119 PMCid:PMC7454371

39. Kabrah SM, Kabrah AM, Flemban AF, Abuzerr S. Systematic review and meta-analysis of the susceptibility of ABO blood group to COVID-19 infection. Transfus Aph Sci. 2021; 60(4):1031-69. doi:10.1016/j.transci.2021.103169 PMid:34045120 PMCid:PMC8139534

40. Gutiérrez‐Valencia M, Leache L, Librero J, Jericó C, Enguita Germán M, García‐Erce JA. ABO blood group and risk of COVID‐19 infection and complications: A systematic review and meta‐analysis. Transfusion. 2022; 62(2): 493-505. doi:10.1111/trf.16748 PMid:34773411 PMCid:PMC8661771

41. Pourali F, Afshari M, Alizadeh-Navaei R, Javidnia J, Moosazadeh M, Hessami A. Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis. New Microb New Infect. 2020; 37(3):100-743. doi:10.1101/2020.06.07.20124610